| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 6.94e-08 | 26 | 31 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.22e-06 | 52 | 31 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity involved in cardiac muscle cell action potential | 3.49e-05 | 6 | 31 | 2 | GO:0086006 | |
| GeneOntologyMolecularFunction | sodium channel inhibitor activity | 6.49e-05 | 8 | 31 | 2 | GO:0019871 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.36e-04 | 171 | 31 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 1.39e-04 | 172 | 31 | 4 | GO:0044325 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.71e-04 | 343 | 31 | 5 | GO:0005261 | |
| GeneOntologyMolecularFunction | sodium ion binding | 2.10e-04 | 14 | 31 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 6.51e-04 | 459 | 31 | 5 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 6.91e-04 | 465 | 31 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 7.41e-04 | 26 | 31 | 2 | GO:0031420 | |
| GeneOntologyMolecularFunction | fatty acyl-CoA hydrolase activity | 7.99e-04 | 27 | 31 | 2 | GO:0047617 | |
| GeneOntologyMolecularFunction | acyl-CoA hydrolase activity | 8.60e-04 | 28 | 31 | 2 | GO:0016289 | |
| GeneOntologyMolecularFunction | channel activity | 1.19e-03 | 525 | 31 | 5 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.20e-03 | 526 | 31 | 5 | GO:0022803 | |
| GeneOntologyMolecularFunction | sodium channel regulator activity | 2.12e-03 | 44 | 31 | 2 | GO:0017080 | |
| GeneOntologyMolecularFunction | thiolester hydrolase activity | 2.41e-03 | 47 | 31 | 2 | GO:0016790 | |
| GeneOntologyMolecularFunction | ion channel inhibitor activity | 2.52e-03 | 48 | 31 | 2 | GO:0008200 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 2.59e-03 | 627 | 31 | 5 | GO:0022890 | |
| GeneOntologyMolecularFunction | channel inhibitor activity | 2.73e-03 | 50 | 31 | 2 | GO:0016248 | |
| GeneOntologyMolecularFunction | transporter inhibitor activity | 2.84e-03 | 51 | 31 | 2 | GO:0141110 | |
| GeneOntologyMolecularFunction | transporter activity | 3.07e-03 | 1289 | 31 | 7 | GO:0005215 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 3.32e-03 | 664 | 31 | 5 | GO:0008324 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 3.78e-03 | 59 | 31 | 2 | GO:0001222 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 4.02e-03 | 1353 | 31 | 7 | GO:0004888 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 5.82e-03 | 758 | 31 | 5 | GO:0015318 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 7.03e-03 | 793 | 31 | 5 | GO:0015075 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 8.66e-03 | 1180 | 31 | 6 | GO:0022857 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.13e-06 | 121 | 32 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 2.34e-06 | 61 | 32 | 4 | GO:0003254 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 2.50e-06 | 62 | 32 | 4 | GO:0086002 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 9.70e-06 | 87 | 32 | 4 | GO:0086001 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 1.26e-05 | 93 | 32 | 4 | GO:0086003 | |
| GeneOntologyBiologicalProcess | response to pyrethroid | 1.40e-05 | 4 | 32 | 2 | GO:0046684 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 2.34e-05 | 36 | 32 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 4.31e-05 | 127 | 32 | 4 | GO:0070252 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 6.09e-05 | 275 | 32 | 5 | GO:0006814 | |
| GeneOntologyBiologicalProcess | response to insecticide | 8.34e-05 | 9 | 32 | 2 | GO:0017085 | |
| GeneOntologyBiologicalProcess | heart contraction | 8.90e-05 | 298 | 32 | 5 | GO:0060047 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 8.90e-05 | 153 | 32 | 4 | GO:0030048 | |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell membrane depolarization | 1.04e-04 | 10 | 32 | 2 | GO:0060371 | |
| GeneOntologyBiologicalProcess | heart process | 1.06e-04 | 309 | 32 | 5 | GO:0003015 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 1.25e-04 | 167 | 32 | 4 | GO:0060048 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 1.92e-04 | 559 | 32 | 6 | GO:0042391 | |
| GeneOntologyBiologicalProcess | self proteolysis | 2.42e-04 | 15 | 32 | 2 | GO:0097264 | |
| GeneOntologyBiologicalProcess | action potential | 2.54e-04 | 201 | 32 | 4 | GO:0001508 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 2.90e-04 | 208 | 32 | 4 | GO:0035725 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 3.40e-04 | 217 | 32 | 4 | GO:0006941 | |
| GeneOntologyBiologicalProcess | blood circulation | 4.24e-04 | 648 | 32 | 6 | GO:0008015 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 4.95e-04 | 100 | 32 | 3 | GO:0061337 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | 5.03e-04 | 1249 | 32 | 8 | GO:0048878 | |
| GeneOntologyBiologicalProcess | regulation of sodium ion transport | 5.10e-04 | 101 | 32 | 3 | GO:0002028 | |
| GeneOntologyBiologicalProcess | membrane depolarization during cardiac muscle cell action potential | 5.78e-04 | 23 | 32 | 2 | GO:0086012 | |
| GeneOntologyBiologicalProcess | metal ion transport | 7.15e-04 | 1000 | 32 | 7 | GO:0030001 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 7.32e-04 | 266 | 32 | 4 | GO:0043270 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial depolarization | 7.99e-04 | 27 | 32 | 2 | GO:0051900 | |
| GeneOntologyBiologicalProcess | circulatory system process | 8.11e-04 | 733 | 32 | 6 | GO:0003013 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | 9.03e-04 | 493 | 32 | 5 | GO:0010959 | |
| GeneOntologyBiologicalProcess | positive regulation of fatty acid biosynthetic process | 9.22e-04 | 29 | 32 | 2 | GO:0045723 | |
| GeneOntologyBiologicalProcess | regulation of circadian rhythm | 1.18e-03 | 135 | 32 | 3 | GO:0042752 | |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cardiac conduction | 1.27e-03 | 34 | 32 | 2 | GO:0086019 | |
| GeneOntologyBiologicalProcess | mitochondrial depolarization | 1.34e-03 | 35 | 32 | 2 | GO:0051882 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.06e-08 | 17 | 32 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.05e-07 | 29 | 32 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | cation channel complex | 2.70e-05 | 235 | 32 | 5 | GO:0034703 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.54e-04 | 378 | 32 | 5 | GO:0034702 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 1.11e-03 | 523 | 32 | 5 | GO:1902495 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 1.24e-03 | 139 | 32 | 3 | GO:0097733 | |
| GeneOntologyCellularComponent | transporter complex | 1.38e-03 | 550 | 32 | 5 | GO:1990351 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 1.63e-03 | 153 | 32 | 3 | GO:0097731 | |
| GeneOntologyCellularComponent | photoreceptor connecting cilium | 2.45e-03 | 48 | 32 | 2 | GO:0032391 | |
| GeneOntologyCellularComponent | non-motile cilium | 3.30e-03 | 196 | 32 | 3 | GO:0097730 | |
| Domain | XK_rel | 7.47e-07 | 11 | 32 | 3 | IPR018629 | |
| Domain | XK-related | 7.47e-07 | 11 | 32 | 3 | PF09815 | |
| Domain | Na_channel_b1/b3 | 2.84e-06 | 2 | 32 | 2 | IPR027098 | |
| Domain | Na_channel_asu | 1.27e-04 | 10 | 32 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 1.27e-04 | 10 | 32 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 1.27e-04 | 10 | 32 | 2 | PF06512 | |
| Domain | Ion_trans_dom | 9.66e-04 | 114 | 32 | 3 | IPR005821 | |
| Domain | Ion_trans | 9.66e-04 | 114 | 32 | 3 | PF00520 | |
| Domain | V-set | 3.78e-03 | 184 | 32 | 3 | PF07686 | |
| Domain | Channel_four-helix_dom | 4.28e-03 | 57 | 32 | 2 | IPR027359 | |
| Domain | - | 4.28e-03 | 57 | 32 | 2 | 1.20.120.350 | |
| Domain | Ig_V-set | 4.71e-03 | 199 | 32 | 3 | IPR013106 | |
| Domain | IQ | 8.47e-03 | 81 | 32 | 2 | SM00015 | |
| Domain | IG_LIKE | 9.47e-03 | 491 | 32 | 4 | PS50835 | |
| Domain | Ig-like_dom | 1.03e-02 | 503 | 32 | 4 | IPR007110 | |
| Domain | IQ_motif_EF-hand-BS | 1.04e-02 | 90 | 32 | 2 | IPR000048 | |
| Domain | EF-hand-dom_pair | 1.28e-02 | 287 | 32 | 3 | IPR011992 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.97e-07 | 31 | 24 | 4 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 2.25e-07 | 32 | 24 | 4 | M27455 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.28e-06 | 130 | 24 | 5 | M27454 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 6.50e-06 | 73 | 24 | 4 | MM16641 | |
| Pathway | WP_DRAVET_SYNDROME | 1.38e-05 | 28 | 24 | 3 | M45519 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.00e-05 | 203 | 24 | 5 | M5485 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.42e-05 | 575 | 24 | 7 | M29853 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 4.80e-05 | 121 | 24 | 4 | M872 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 6.69e-05 | 47 | 24 | 3 | M42524 | |
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 1.55e-07 | 12 | 32 | 3 | 30175250 | |
| Pubmed | HNF4 alpha and the Ca-channel TRPC1 are novel disease candidate genes in diabetic nephropathy. | 8.20e-07 | 2 | 32 | 2 | 18184923 | |
| Pubmed | Study of the residues involved in the binding of β1 to β3 subunits in the sodium channel. | 8.20e-07 | 2 | 32 | 2 | 24581800 | |
| Pubmed | Structural basis for modulation of human NaV1.3 by clinical drug and selective antagonist. | 2.46e-06 | 3 | 32 | 2 | 35277491 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 20966350 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 16052353 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 25971967 | ||
| Pubmed | Sudden infant death syndrome-associated mutations in the sodium channel beta subunits. | 4.92e-06 | 4 | 32 | 2 | 20226894 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 11470829 | ||
| Pubmed | Contribution of Cardiac Sodium Channel β-Subunit Variants to Brugada Syndrome. | 4.92e-06 | 4 | 32 | 2 | 26179811 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 21051419 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 35801810 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 8.05e-06 | 139 | 32 | 4 | 16985003 | |
| Pubmed | Mutations in sodium channel β1- and β2-subunits associated with atrial fibrillation. | 8.19e-06 | 5 | 32 | 2 | 19808477 | |
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 9647734 | ||
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 24337656 | ||
| Pubmed | Nuclear receptor HNF4A transrepresses CLOCK:BMAL1 and modulates tissue-specific circadian networks. | 1.72e-05 | 7 | 32 | 2 | 30530698 | |
| Pubmed | 2.14e-05 | 371 | 32 | 5 | 15747579 | ||
| Pubmed | The identification of different endothelial cell populations within the mouse proepicardium. | 2.29e-05 | 8 | 32 | 2 | 21932312 | |
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 25757662 | ||
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 23746980 | ||
| Pubmed | Endothelial cells are not required for specification of respiratory progenitors. | 2.94e-05 | 9 | 32 | 2 | 28501476 | |
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 20159955 | ||
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 15746173 | ||
| Pubmed | Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. | 2.94e-05 | 9 | 32 | 2 | 17884088 | |
| Pubmed | Exposure of phosphatidylserine by Xk-related protein family members during apoptosis. | 3.67e-05 | 10 | 32 | 2 | 25231987 | |
| Pubmed | 6.36e-05 | 13 | 32 | 2 | 22051675 | ||
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 8.55e-05 | 15 | 32 | 2 | 9726281 | |
| Pubmed | 8.55e-05 | 15 | 32 | 2 | 20692235 | ||
| Pubmed | Small intestinal resident eosinophils maintain gut homeostasis following microbial colonization. | 1.11e-04 | 17 | 32 | 2 | 35709757 | |
| Pubmed | Loss of PiT-1 results in abnormal endocytosis in the yolk sac visceral endoderm. | 1.11e-04 | 17 | 32 | 2 | 25138534 | |
| Pubmed | 1.11e-04 | 17 | 32 | 2 | 29764841 | ||
| Pubmed | 1.11e-04 | 101 | 32 | 3 | 10997877 | ||
| Pubmed | Genetic lineage tracing identifies endocardial origin of liver vasculature. | 1.24e-04 | 18 | 32 | 2 | 27019112 | |
| Pubmed | 1.70e-04 | 21 | 32 | 2 | 30270038 | ||
| Pubmed | Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. | 1.87e-04 | 22 | 32 | 2 | 9136933 | |
| Pubmed | 2.24e-04 | 24 | 32 | 2 | 20301690 | ||
| Pubmed | 2.43e-04 | 25 | 32 | 2 | 23554936 | ||
| Pubmed | 2.43e-04 | 25 | 32 | 2 | 36046192 | ||
| Pubmed | Mab21l2 is essential for embryonic heart and liver development. | 2.43e-04 | 25 | 32 | 2 | 22412967 | |
| Pubmed | Deletion of Pdcd5 in mice led to the deficiency of placenta development and embryonic lethality. | 2.84e-04 | 27 | 32 | 2 | 28542142 | |
| Pubmed | 2.84e-04 | 27 | 32 | 2 | 35377412 | ||
| Pubmed | 3.05e-04 | 28 | 32 | 2 | 16109169 | ||
| Pubmed | ER71 acts downstream of BMP, Notch, and Wnt signaling in blood and vessel progenitor specification. | 3.51e-04 | 30 | 32 | 2 | 18462699 | |
| Pubmed | 5.65e-04 | 38 | 32 | 2 | 25572963 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 7.02e-04 | 1201 | 32 | 6 | 35696571 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 9.67e-05 | 127 | 32 | 3 | chr2q24 | |
| GeneFamily | Blood group antigens|XK related family | 2.21e-07 | 11 | 21 | 3 | 955 | |
| GeneFamily | V-set domain containing|Immunoglobulin like domain containing|Sodium voltage-gated channel beta subunits | 7.70e-06 | 4 | 21 | 2 | 1204 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 8.49e-04 | 163 | 21 | 3 | 590 | |
| GeneFamily | Immunoglobulin like domain containing | 1.38e-03 | 193 | 21 | 3 | 594 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.48e-02 | 161 | 21 | 2 | 593 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 7.48e-06 | 182 | 31 | 4 | 7af3b2029b7f55b923d5a4b764d4292f4ea48599 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 7.48e-06 | 182 | 31 | 4 | ea4f6c8f600ffe9f8e0609637b3371a5ac48ca03 | |
| ToppCell | E18.5-samps-Endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 7.48e-06 | 182 | 31 | 4 | e2d799e6e7526176a6fe6515b8fbe4d83d3a3ea1 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.15e-06 | 186 | 31 | 4 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.51e-06 | 188 | 31 | 4 | 36ff615154d6d9e3ba6ccb73a0f11574bcbf5ece | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Fibroblasts|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.82e-06 | 195 | 31 | 4 | 5870b2956d50d6550a3174a220a6cc70c5538d70 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.00e-05 | 196 | 31 | 4 | d37d821229dce716a05c2a5865415e10f79032de | |
| ToppCell | distal-1-mesenchymal-Alveolar_Fibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.04e-05 | 198 | 31 | 4 | 6594c35ab203dc51462167c61807b0d49fa30fb2 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-05 | 200 | 31 | 4 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O1-Trf|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.01e-05 | 76 | 31 | 3 | efbbbf91bca35720d8ecddb076f2c9f4de25e44d | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.01e-05 | 76 | 31 | 3 | 254d18bece2676faa4bbeb8d48b1d327ab3c2215 | |
| ToppCell | lymphoid-T_cell-pro-T_cell|lymphoid / Lineage, cell class and subclass | 4.31e-05 | 98 | 31 | 3 | 4da11182885d5f2673e85bd9c5717939b0268427 | |
| ToppCell | Endothelial-G|World / shred on cell class and cell subclass (v4) | 8.68e-05 | 124 | 31 | 3 | 4b72809463f2986b7d1b7ab9de633ac4d7854a92 | |
| ToppCell | CTRL-Lymphoid-pDC|CTRL / Disease state, Lineage and Cell class | 1.22e-04 | 139 | 31 | 3 | bbc10812b0c5b8c85e78171c12316becde8895c3 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.59e-04 | 152 | 31 | 3 | 32634195048858ae84605c61e43c542d90f7cab5 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.59e-04 | 152 | 31 | 3 | 0eb185b2404f015efff1bd140e0c502d714720fb | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 1.71e-04 | 156 | 31 | 3 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 1.71e-04 | 156 | 31 | 3 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | 3'_v3-blood-Lymphocytic_Invariant-Inducer-like-ILC3|blood / Manually curated celltypes from each tissue | 1.74e-04 | 157 | 31 | 3 | eb2520c237543ea4869d4386afc0457b111f6193 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.74e-04 | 157 | 31 | 3 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.78e-04 | 158 | 31 | 3 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic-mast_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.81e-04 | 159 | 31 | 3 | ecd1daa33549541aee3bf4e139ab6732efc8e74c | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.81e-04 | 159 | 31 | 3 | 7b6370c9567da7d40541c6e243efa704ed7e90ae | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.84e-04 | 160 | 31 | 3 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.84e-04 | 160 | 31 | 3 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-04 | 161 | 31 | 3 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-04 | 161 | 31 | 3 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-04 | 161 | 31 | 3 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-04 | 162 | 31 | 3 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.95e-04 | 163 | 31 | 3 | d6f9b7280c44d120df5a72dfc2ebb26ffbb5752b | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-04 | 165 | 31 | 3 | 347b59aa625a8a960828b8620824d8ac48990e07 | |
| ToppCell | Endothelial-B-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 2.02e-04 | 165 | 31 | 3 | b6893882472aeb0d18e26f47eaec9d53688afcde | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-04 | 165 | 31 | 3 | 1890f9c33b0c5b381d57f97042da2610a093a6de | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.02e-04 | 165 | 31 | 3 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-04 | 165 | 31 | 3 | 507c89ece0a336b8e9c65b79889a714e17ddca27 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-04 | 165 | 31 | 3 | 39a25be081a5d59c7cf107a997d352793d5025fb | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.02e-04 | 165 | 31 | 3 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.02e-04 | 165 | 31 | 3 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.05e-04 | 166 | 31 | 3 | 6bd5aa205b6e4b88ba9f8cd0999e2191d7d1d16c | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.05e-04 | 166 | 31 | 3 | 5ba45407a47207ff01e4a3f9f5d91d8247fe9b6f | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 166 | 31 | 3 | aa2df07eff323ded751ced8938af08223d7f2029 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 166 | 31 | 3 | 695298a94d62b8adab083900003ec636fbaae5d9 | |
| ToppCell | Endothelial-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.05e-04 | 166 | 31 | 3 | c286987ea4e511195607c87ec4529c2c2ed2122e | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.09e-04 | 167 | 31 | 3 | c0c944eae0514dc8e00d0c2892a0792e157695ec | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.13e-04 | 168 | 31 | 3 | 55c9de7b3a1d6cf7b02b020ff92ab4ede8d195cc | |
| ToppCell | Endothelial-B-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 2.13e-04 | 168 | 31 | 3 | 4977c3837fbb1f36c89fddd5764e37290ac25ad8 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-04 | 169 | 31 | 3 | f077e39e41fffe7672541f5b72b80faaf56c597c | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-04 | 169 | 31 | 3 | 41ad349806b279fbe1374b7e3cc7f146a11adb44 | |
| ToppCell | Endothelial-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.17e-04 | 169 | 31 | 3 | 95c617143e1fbdd1d55a93ffdcc210e0be37cf2f | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 169 | 31 | 3 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 2.17e-04 | 169 | 31 | 3 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | Endothelial-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.17e-04 | 169 | 31 | 3 | 8889c9e8af1ab0b093d57b69abd80b59b3461be9 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-04 | 169 | 31 | 3 | 42782c61592742190ab0cba8a94f8bdf9c278f90 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-04 | 170 | 31 | 3 | 35e3945d8a540a3e2cec1b559316265aaad023d1 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-04 | 170 | 31 | 3 | a6fa0cab1fa829ec601fe48306b4c43c83425b04 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-04 | 170 | 31 | 3 | b40255eee45eb18b5a297336d7f3845fd8f8aa3b | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 2.20e-04 | 170 | 31 | 3 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-04 | 170 | 31 | 3 | 0ea625abaa25bab93b70b7000e8f90d5c0f9a0fb | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-04 | 170 | 31 | 3 | 0b5ddc7d452db0a389927a367914f7d257703f7e | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_Erythro-Mega|lymph-node_spleen / Manually curated celltypes from each tissue | 2.24e-04 | 171 | 31 | 3 | 3ecd0a074344179c57eb2d9a857ba594904d00fa | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.28e-04 | 172 | 31 | 3 | 490745024730df6357f6c2b81d7a64e21557c0d5 | |
| ToppCell | 3'_v3-blood-Mast|blood / Manually curated celltypes from each tissue | 2.28e-04 | 172 | 31 | 3 | e7a46bbeff749ca59b9f1357409ce1ad59dd22dd | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.28e-04 | 172 | 31 | 3 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | Endothelial-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.28e-04 | 172 | 31 | 3 | 8a527dff06d841a86c7eb04a1dd9630787294da4 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-04 | 173 | 31 | 3 | 7dc988fc0ba29990567bf1bcdeb3faeeee507eb1 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 2.32e-04 | 173 | 31 | 3 | 42c911ed16fabdabef063830e8407192d8bde950 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 2.32e-04 | 173 | 31 | 3 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.32e-04 | 173 | 31 | 3 | 1edef5aeab626cbf2c09468e77b02cfa2d21ba03 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.32e-04 | 173 | 31 | 3 | c37dba3804df7c3151e18e6ae4e0b6e7a92bae97 | |
| ToppCell | Endothelial-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.32e-04 | 173 | 31 | 3 | a81992965137195d20fc498f750975303961a828 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.32e-04 | 173 | 31 | 3 | 5b76d9cc56bbb29017e64a2d0a3c76c0be003d96 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.32e-04 | 173 | 31 | 3 | bf685025961e79b379f2c35464b6c8ce3e31ace0 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.32e-04 | 173 | 31 | 3 | a6e73a40b0d5356564a594053e772f9d061a5919 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-04 | 173 | 31 | 3 | a7dee23b1d43d3070d502487af319ff81a9a747b | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.32e-04 | 173 | 31 | 3 | a8b5370f4c893a20c58e97659f3ac168699693f8 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.36e-04 | 174 | 31 | 3 | b4f3f5334803e5903bc496decf923f2e44f7fa3c | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.36e-04 | 174 | 31 | 3 | cb0109661e8c9ca04d67d33f2d926f0e649bf67d | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.36e-04 | 174 | 31 | 3 | 2627c3983009839fedbc5e3f628739dc026447f4 | |
| ToppCell | 10x5'-GI_small-bowel-Mast|GI_small-bowel / Manually curated celltypes from each tissue | 2.36e-04 | 174 | 31 | 3 | e94c980b25edfd0e8598c416828801fcc00e8ead | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-04 | 174 | 31 | 3 | 46bd0ef7d0541386de7a901d85d53d0176dc92bf | |
| ToppCell | 10x5'-GI_small-bowel-Mast-Mast_cells|GI_small-bowel / Manually curated celltypes from each tissue | 2.36e-04 | 174 | 31 | 3 | 05525bf0a2bde2be4f7c147b17a24530ce8819e0 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.36e-04 | 174 | 31 | 3 | 507a33e58f62e2b72f0bcc743e84dbd0bf705a15 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-04 | 175 | 31 | 3 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.40e-04 | 175 | 31 | 3 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 176 | 31 | 3 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.44e-04 | 176 | 31 | 3 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3-5_THEMIS_ELOF1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-04 | 176 | 31 | 3 | 78306517b1e52411a2ba72f141efea4d12c09f25 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 176 | 31 | 3 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.48e-04 | 177 | 31 | 3 | 2b675840b7d2bb536c2c600936733bd9e97e7120 | |
| ToppCell | Severe_COVID-19-Myeloid-Neutrophil|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.48e-04 | 177 | 31 | 3 | a6fae376f1beb1df423484d9b1bd1d954ca117af | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.48e-04 | 177 | 31 | 3 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.48e-04 | 177 | 31 | 3 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.52e-04 | 178 | 31 | 3 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.52e-04 | 178 | 31 | 3 | 982205ba117a4c7b7e9b713689a5b69190f0bca9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.52e-04 | 178 | 31 | 3 | 674ee5095b98929c29e4f6bd56029a336cc4a38c | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.56e-04 | 179 | 31 | 3 | 35fe9961e228ce255e3317fc244efa35b5adbf8b | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.56e-04 | 179 | 31 | 3 | ab3d08b51cd7a37582305615ee221c7a2af83b40 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.56e-04 | 179 | 31 | 3 | 87f608b137aae34572b150492a83a3a127cff40b | |
| ToppCell | 3'_v3-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue | 2.61e-04 | 180 | 31 | 3 | b37ee81b792213d6595b4ec65d04bc35d83321c7 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.61e-04 | 180 | 31 | 3 | efc4c5a4dea456527526bbfd88cf70d803893671 | |
| Drug | diprafenone | 1.23e-08 | 19 | 32 | 4 | CID000071249 | |
| Drug | AC1NT1AF | 3.98e-08 | 25 | 32 | 4 | CID005322157 | |
| Drug | Pirmenolum | 4.70e-08 | 26 | 32 | 4 | CID000004853 | |
| Drug | fenpropathrin | 5.03e-08 | 6 | 32 | 3 | ctd:C044267 | |
| Drug | AC1L1MOZ | 5.51e-08 | 27 | 32 | 4 | CID000031958 | |
| Drug | nefopam | 5.51e-08 | 27 | 32 | 4 | CID000004450 | |
| Drug | PbTx-1 | 5.51e-08 | 27 | 32 | 4 | CID006437089 | |
| Drug | paraben | 6.42e-08 | 28 | 32 | 4 | CID000007175 | |
| Drug | tocainide | 8.58e-08 | 30 | 32 | 4 | CID000038945 | |
| Drug | NSC93767 | 1.12e-07 | 32 | 32 | 4 | CID000005658 | |
| Drug | 5-hydroxypropafenone | 1.45e-07 | 34 | 32 | 4 | CID000107927 | |
| Drug | benzocaine | 2.05e-07 | 37 | 32 | 4 | CID000002337 | |
| Drug | aprindine | 2.29e-07 | 38 | 32 | 4 | CID000002218 | |
| Drug | trimethoprim | 2.58e-07 | 99 | 32 | 5 | CID000005578 | |
| Drug | S-ropivacaine | 2.83e-07 | 40 | 32 | 4 | CID000071273 | |
| Drug | pilsicainide | 5.03e-07 | 46 | 32 | 4 | CID000004820 | |
| Drug | spiradoline | 5.03e-07 | 46 | 32 | 4 | CID000005620 | |
| Drug | indoxacarb | 6.51e-07 | 49 | 32 | 4 | CID000107720 | |
| Drug | AC1NSN3X | 9.67e-07 | 54 | 32 | 4 | CID005366189 | |
| Drug | AC1L1W4O | 1.13e-06 | 15 | 32 | 3 | CID000036625 | |
| Drug | triamterene | 1.29e-06 | 58 | 32 | 4 | CID000005546 | |
| Drug | zonisamide | 1.69e-06 | 62 | 32 | 4 | CID000005734 | |
| Drug | saxitoxin | 2.05e-06 | 65 | 32 | 4 | CID000037165 | |
| Drug | AC1L1CQC | 2.05e-06 | 65 | 32 | 4 | CID000002012 | |
| Drug | mexiletine | 2.18e-06 | 66 | 32 | 4 | CID000004178 | |
| Drug | resiniferatoxin | 2.18e-06 | 66 | 32 | 4 | CID000104826 | |
| Drug | disopyramide | 2.18e-06 | 66 | 32 | 4 | CID000003114 | |
| Drug | dibucaine | 2.46e-06 | 68 | 32 | 4 | CID000003025 | |
| Drug | GBR 12909 | 2.61e-06 | 69 | 32 | 4 | CID000003455 | |
| Drug | T2755 | 2.92e-06 | 71 | 32 | 4 | CID000005514 | |
| Drug | flecainide | 2.92e-06 | 71 | 32 | 4 | CID000003355 | |
| Drug | imide | 3.45e-06 | 74 | 32 | 4 | CID000443040 | |
| Drug | 1, 3-diallylurea | 3.45e-06 | 74 | 32 | 4 | CID000074537 | |
| Drug | diphenhydramine | 3.64e-06 | 75 | 32 | 4 | CID000003100 | |
| Drug | fenfluramine | 4.68e-06 | 178 | 32 | 5 | CID000003337 | |
| Drug | bupropion | 4.95e-06 | 81 | 32 | 4 | CID000000444 | |
| Drug | strychnine HCl | 5.08e-06 | 181 | 32 | 5 | CID000005304 | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; HL60; HG-U133A | 7.68e-06 | 197 | 32 | 5 | 1394_DN | |
| Drug | cyfluthrin | 8.99e-06 | 29 | 32 | 3 | ctd:C052570 | |
| Drug | propafenone | 1.06e-05 | 98 | 32 | 4 | CID000004932 | |
| Drug | pyrethrin | 1.10e-05 | 31 | 32 | 3 | CID000011442 | |
| Drug | isradipine | 1.15e-05 | 100 | 32 | 4 | CID000003784 | |
| Drug | AC1NPPZW | 1.29e-05 | 103 | 32 | 4 | CID005183170 | |
| Drug | pentobarbital | 1.43e-05 | 224 | 32 | 5 | CID000004737 | |
| Drug | lamotrigine | 2.06e-05 | 116 | 32 | 4 | CID000003878 | |
| Drug | hydrochlorothiazide | 2.35e-05 | 120 | 32 | 4 | CID000003639 | |
| Drug | bupivacaine | 2.76e-05 | 125 | 32 | 4 | CID000002474 | |
| Drug | bepridil | 2.85e-05 | 126 | 32 | 4 | CID000002351 | |
| Drug | ketamine | 3.03e-05 | 262 | 32 | 5 | CID000003821 | |
| Drug | manganese chloride | 3.64e-05 | 456 | 32 | 6 | ctd:C025340 | |
| Drug | triphosphoinositide | 3.69e-05 | 273 | 32 | 5 | CID009543520 | |
| Drug | isoflurane | 4.09e-05 | 279 | 32 | 5 | CID000003763 | |
| Drug | clenbuterol | 4.55e-05 | 142 | 32 | 4 | CID000002783 | |
| Drug | salbutamol | 5.07e-05 | 146 | 32 | 4 | CID000002083 | |
| Drug | lacosamide | 5.32e-05 | 52 | 32 | 3 | CID000219078 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 5.33e-05 | 8 | 32 | 2 | ctd:C489827 | |
| Drug | procaine | 6.09e-05 | 153 | 32 | 4 | CID000004914 | |
| Drug | dihydrochloride | 7.07e-05 | 159 | 32 | 4 | CID000070978 | |
| Drug | lidocaine | 7.24e-05 | 160 | 32 | 4 | CID000003676 | |
| Drug | amiodarone | 7.24e-05 | 160 | 32 | 4 | CID000002156 | |
| Drug | gabapentin | 8.96e-05 | 169 | 32 | 4 | CID000003446 | |
| Drug | riluzole | 1.00e-04 | 174 | 32 | 4 | CID000005070 | |
| Drug | toluene | 1.02e-04 | 175 | 32 | 4 | CID000001140 | |
| Drug | RH-3421 | 1.04e-04 | 11 | 32 | 2 | CID000108039 | |
| Drug | chloroacetylajmaline | 1.04e-04 | 11 | 32 | 2 | CID000038681 | |
| Drug | carbamazepine | 1.12e-04 | 179 | 32 | 4 | CID000002554 | |
| Drug | NSC7524 | 1.19e-04 | 182 | 32 | 4 | CID000005657 | |
| Drug | pseudococaine | 1.25e-04 | 570 | 32 | 6 | CID000002826 | |
| Drug | Ro 22-9194 | 1.25e-04 | 12 | 32 | 2 | CID000129209 | |
| Drug | synthetic pyrethrins | 1.35e-04 | 71 | 32 | 3 | CID000002982 | |
| Drug | Pyrethroids | 1.35e-04 | 71 | 32 | 3 | CID000005053 | |
| Drug | procainamide | 1.41e-04 | 190 | 32 | 4 | CID000004913 | |
| Drug | propofol | 1.44e-04 | 191 | 32 | 4 | CID000004943 | |
| Drug | CID6432355 | 1.48e-04 | 13 | 32 | 2 | CID006432355 | |
| Drug | AC1LCJM3 | 1.48e-04 | 13 | 32 | 2 | CID000631640 | |
| Drug | Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 7325_DN | |
| Drug | vinblastine sulfate; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 7517_DN | |
| Drug | Sotalol hydrochloride [959-24-0]; Up 200; 13uM; PC3; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 4079_UP | |
| Drug | gadolinium | 1.68e-04 | 199 | 32 | 4 | CID000023982 | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A | 1.71e-04 | 200 | 32 | 4 | 5603_DN | |
| Drug | bioallethrin | 1.72e-04 | 14 | 32 | 2 | ctd:C018465 | |
| Drug | lorcainide | 1.72e-04 | 14 | 32 | 2 | CID000042883 | |
| Drug | octylguanidine | 1.72e-04 | 14 | 32 | 2 | CID000030621 | |
| Drug | valproate | 1.77e-04 | 381 | 32 | 5 | CID000003121 | |
| Drug | trimethyloxonium | 1.99e-04 | 15 | 32 | 2 | CID000093245 | |
| Drug | QX-314 | 2.07e-04 | 82 | 32 | 3 | CID000003925 | |
| Drug | Sodium | 2.22e-04 | 84 | 32 | 3 | ctd:D012964 | |
| Drug | trans-permethrin | 2.38e-04 | 86 | 32 | 3 | CID000040159 | |
| Drug | quindine | 2.42e-04 | 219 | 32 | 4 | CID000001065 | |
| Drug | phenytoin | 2.42e-04 | 219 | 32 | 4 | CID000001775 | |
| Drug | Asbestos, Crocidolite | 2.48e-04 | 1241 | 32 | 8 | ctd:D017638 | |
| Drug | articaine | 2.57e-04 | 17 | 32 | 2 | CID000032169 | |
| Drug | lifarizine | 2.57e-04 | 17 | 32 | 2 | CID000071336 | |
| Drug | sodium | 2.79e-04 | 944 | 32 | 7 | CID000000923 | |
| Drug | moricizine | 2.89e-04 | 18 | 32 | 2 | CID000034632 | |
| Drug | fenvalerate | 3.40e-04 | 97 | 32 | 3 | ctd:C017690 | |
| Drug | BDF 9148 | 3.95e-04 | 21 | 32 | 2 | CID000123765 | |
| Drug | lactate | 4.27e-04 | 461 | 32 | 5 | CID000000612 | |
| Drug | pyraclofos | 4.41e-04 | 106 | 32 | 3 | CID000093460 | |
| Drug | AC1L1CD9 | 4.75e-04 | 23 | 32 | 2 | CID000001844 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.53e-07 | 12 | 32 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Brugada syndrome | 3.18e-05 | 8 | 32 | 2 | cv:C1142166 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 4.08e-05 | 9 | 32 | 2 | C3502809 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 5.10e-05 | 10 | 32 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 5.10e-05 | 10 | 32 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Other specified cardiac arrhythmias | 6.23e-05 | 11 | 32 | 2 | C0348626 | |
| Disease | Nodal rhythm disorder | 6.23e-05 | 11 | 32 | 2 | C0264893 | |
| Disease | Ectopic rhythm | 6.23e-05 | 11 | 32 | 2 | C1399226 | |
| Disease | CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder) | 6.23e-05 | 11 | 32 | 2 | C2748542 | |
| Disease | Brugada Syndrome 1 | 8.82e-05 | 13 | 32 | 2 | C4551804 | |
| Disease | Sinus Node Dysfunction (disorder) | 1.19e-04 | 15 | 32 | 2 | C0428908 | |
| Disease | Acute Lung Injury | 2.60e-04 | 22 | 32 | 2 | C0242488 | |
| Disease | ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder) | 2.60e-04 | 22 | 32 | 2 | C1843687 | |
| Disease | Brugada Syndrome (disorder) | 3.10e-04 | 24 | 32 | 2 | C1142166 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 5.40e-04 | 147 | 32 | 3 | DOID:9352 (biomarker_via_orthology) | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 1.10e-03 | 45 | 32 | 2 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 1.10e-03 | 45 | 32 | 2 | EFO_0004623, EFO_0004792 | |
| Disease | obesity (implicated_via_orthology) | 1.62e-03 | 215 | 32 | 3 | DOID:9970 (implicated_via_orthology) | |
| Disease | Ischemic stroke, fibrinogen measurement | 1.63e-03 | 55 | 32 | 2 | EFO_0004623, HP_0002140 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MKYLEESVWLHLLII | 1416 | Q8WXG9 | |
| VFIVKMWRLLIYETE | 821 | P49756 | |
| VVMVIVVILYWKLCR | 1311 | Q9HCM3 | |
| QINLILLERLWYVML | 316 | P33897 | |
| YLTWILDVLEKIRPM | 251 | Q86YW9 | |
| EIKKLIYVHLVIWLL | 36 | Q8N5M9 | |
| IYVHLVIWLLLVAKM | 41 | Q8N5M9 | |
| VIIYMALLHLWVMIV | 701 | Q8TBA6 | |
| MKEQLLVLVEWAKYI | 191 | P41235 | |
| VIKYVLQDPIWLLMA | 1121 | O15534 | |
| KIMLLVILLFVLSWA | 296 | Q9UHM6 | |
| LVIILKMFWIEATLL | 346 | Q01638 | |
| MKILLIIFVLIIWTE | 1 | A8TX70 | |
| FILKIMLPYWEVALV | 266 | Q5T6L9 | |
| IIKLNVLEWLQLTMY | 806 | P20807 | |
| IWLYLAELVTPMLKE | 1316 | O43432 | |
| YLKWRVNKVILMILL | 121 | Q9NYV9 | |
| LLYVIIMAEKVLWVL | 136 | Q8NGG5 | |
| IMAEKVLWVLVIVPY | 141 | Q8NGG5 | |
| VFTYIFILEMLLKWV | 1246 | Q9NY46 | |
| SMKITWYILVLLVFI | 211 | Q8N614 | |
| LEVDEITLWYKMILP | 511 | Q12884 | |
| ERIDYLLILWIIGMI | 421 | P48995 | |
| IWVFLFKLLILQYLM | 2066 | Q63HN8 | |
| MIILIYLFLLLWEDT | 1 | P98066 | |
| AIKLQVIKLIYLMIW | 36 | O14609 | |
| VIKLIYLMIWHSLVI | 41 | O14609 | |
| VWLLLLYFMQVIAIV | 101 | Q9UMS5 | |
| MILWFLYIFVLEIKL | 76 | Q9BTD3 | |
| IMMYVLIVVLTIWLV | 161 | Q07699 | |
| LIVVLTIWLVAEMIY | 166 | Q07699 | |
| MMYILLVFLTLWLLI | 161 | Q9NY72 | |
| AIKLQVIKLIYLMIW | 36 | A2RUG3 | |
| VIKLIYLMIWHSLVI | 41 | A2RUG3 | |
| LISWLIIVNMYIVVV | 1481 | Q01118 | |
| MFFWLLLVIILRTVK | 776 | P35968 | |
| YMIRFIENAILLLLW | 321 | P51811 | |
| WMLSVVLLLFLNVKI | 216 | Q5GH70 |